title: Procalcitonin: a marker of infection not subverted by treatment with interleukin-6 receptor inhibition.
authors.affiliation: Department of Pediatrics, Section on Infectious Diseases Department of Pediatrics, Section of Allergy, Immunology and Rheumatology, University of Colorado School of Medicine, Aurora, CO Department of Pediatrics, Section on Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, Center for Global Health, Colorado School of Public Health, Aurora, CO.
authors.forename: James T
authors.initials: JT
authors.lastname: Gaensbauer
authors.forename: Craig A
authors.initials: CA
authors.lastname: Press
authors.forename: J Roger
authors.initials: JR
authors.lastname: Hollister
authors.forename: Edwin J
authors.initials: EJ
authors.lastname: Asturias
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects; D001424:Bacterial Infections / Q000175:diagnosis* / Q000473:pathology*; D015415:Biomarkers / Q000097:blood*; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D011498:Protein Precursors / Q000097:blood*; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; C000606589:CALCA protein, human; D007166:Immunosuppressive Agents; D011498:Protein Precursors; D019947:Receptors, Interleukin-6; D002116:Calcitonin; C502936:tocilizumab; D015740:Calcitonin Gene-Related Peptide